Skip to content

Methylergonovine

Methergine (methylergonovine) is a small molecule pharmaceutical. Methylergonovine was first approved as Methergine on 1982-01-01. It is used to treat postpartum hemorrhage in the USA. It is known to target 5-hydroxytryptamine receptor 1E, 5-hydroxytryptamine receptor 2C, 5-hydroxytryptamine receptor 1F, 5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2B, and Soluble cytochrome b562.
Trade Name Methergine
Common Name Methylergonovine
Indication postpartum hemorrhage
Drug Class Ergot alkaloid derivatives; vinca alkaloids
Methylergonovine
Get full access now